Delineating the Significance of Several Inflammatory Markers in a Lung Tuberculosis Cohort During the Active and Post-Tuberculosis Stages of the Disease: An Observational Study in Cape Town, South Africa (2019 to 2024)
Authors:
- Chrisstoffel JumaarCJChrisstoffel Jumaar
- Lindiwe MalefaneLMLindiwe Malefane
- Steve JacobsSJSteve Jacobs
- Olakunle SanniOSOlakunle Sanni
- Elize LouwELElize Louw
- Nicola BainesNBNicola Baines
- Carmen PayneCPCarmen Payne
- Sigrid SchulzSSSigrid Schulz
- Carl LombardCLCarl Lombard
- Merga FeyasaMFMerga Feyasa
- David MareeDMDavid Maree
- Shantal WindvogelSWShantal Windvogel
Open Access
- 9 May 2025
- journal article
- research article
- Published by MDPI AG in Infectious Disease Reports
- Vol. 17 (3) , 52
Abstract
Background: Pulmonary tuberculosis (TB) frequently leads to long-term lung complications that contribute to increased mortality. Understanding the pathogenesis of post-TB lung impairments is crucial for improving long-term outcomes in TB patients; yet this area remains poorly researched. Methods: Our study assessed circulatory inflammatory markers in patients who completed TB treatment more than one year before enrolment (population 1) and patients receiving in-hospital treatment for active drug-sensitive TB (population 2). Results: IL-6 was seven times higher in both populations compared to the normal range. IL-8 was below the limit of detection (LOD) in population 1, while it was approximately 2.5 times higher in population 2 compared to the normal range. TNF-α was 21 times higher in population 1 and 19 times higher in population 2 compared to the normal range. CRP was almost 49 times higher in both populations, and IL-1Ra was below the LOD in population 1, while it was ~1.5 times higher in population 2 compared to the normal range. Conclusions: These inflammatory biomarkers correlated well with lung function in the post-TB state, and their high levels suggest a persistent pro-inflammatory state post-TB, which may contribute to post-TB lung disease. More research is warranted to better understand this phenomenon, but these findings may highlight a need to consider anti-inflammatory therapy for patients with post-TB lung disease, especially since these high levels of cytokines can directly contribute to lung damage.Keywords
Funding Information
- NIHR Global Health Research Unit on Lung Health and Tuberculosis in Africa at LSTM (IMPALA) (16/136/35, RP10090, 35671, K2443)
- South African Medical Research Council (16/136/35, RP10090, 35671, K2443)
- National Research Foundation of South Africa (16/136/35, RP10090, 35671, K2443)
- Harry Crossley Foundation and the Faculty of Health Sciences, Stellenbosch University for Early Career Research Funding (16/136/35, RP10090, 35671, K2443)
This publication has 39 references indexed in Scilit:
- Post-tuberculosis lung disease and inflammatory role players: can we characterise the myriad inflammatory pathways involved to gain a better understanding?Chemico-Biological Interactions, 2023
- The prevalence of pulmonary hypertension after successful tuberculosis treatment in a community sample of adult patientsPulmonary Circulation, 2023
- Interleukin-1 and Related Cytokines in the Regulation of Inflammation and ImmunityImmunity, 2019
- Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical TrialEBioMedicine, 2017
- Interleukin-6 Signaling Drives Fibrosis in Unresolved InflammationImmunity, 2014
- Dying to Live: How the Death Modality of the Infected Macrophage Affects Immunity to Tuberculosis2013
- Interleukin-6: from an inflammatory marker to a target for inflammatory diseasesTrends in Immunology, 2012
- The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous InfectionCell, 2009
- New insights into the function of granulomas in human tuberculosisThe Journal of Pathology, 2005
- TNFα-mediated tissue damage in mouse footpads primed with mycobacterial preparationsResearch in Immunology, 1992